As of the 24 September 2015 The Centre for Ageing Research and Development in Ireland (CARDI) became the Ageing Research and Development Division within the Institute of Public Health in Ireland (IPH).
This website will remain online but will no longer be updated. To keep up to date with our work please visit the Division of Ageing Research and Development section of the IPH website.
Older people in Northern Ireland are more likely to suffer from coronary heart disease than those in the Republic of Ireland. They are also far more likely to have a limiting long-term illness and disability, according to a study funded by CARDI launched today (Thursday 26 March 2015) in Belfast.
The study was led by researchers from the UKCRC Centre of Excellence for Public Health at Queen’s University Belfast.
Prevalence of heart disease and rates of associated disability are higher among men and those in lower socio-economic groups in both countries.
Ageing research flourishes when the research community connects with the relevant players from government, voluntary and community sector, business and older people themselves. As a result many funders of research and researchers themselves are recognising the benefits of engaging with service users. This research, carried out by Dr Brendan Murtagh, QUB on behalf of CARDI funded by OFMDFM (NI), reviews the nature of user involvement in research and how this can be strengthened to improve the quality of age research in Ireland, North and South.
Older people are being denied proper access to cancer care, an academic has claimed.
A high proportion of older women with a certain form of breast cancer receive less chemotherapy than their younger counterparts, Professor Mark Lawler from Queen's University Belfast said. Read more here.
Dr Eugene O’Hare, Queen's University Belfast, hopes his research may help provide a treatment for a disease which touches the lives of millions of people throughout the world – Alzheimer’s. He is collaborating with Senexis Ltd, a Cambridge- based drug-development company that is focused on discovering new compounds for the treatment of dementia. Read more here.